Literature DB >> 28093873

Diagnostic and management challenges from childhood, puberty through to transition in severe insulin resistance due to insulin receptor mutations.

Christina Wei1,2, Christine P Burren1.   

Abstract

Two Caucasian girls, both of normal weight and body mass indices, were diagnosed with type A insulin resistance (IR) in childhood. Case 1 presented with premature adrenarche aged 7 years, then by age 12 years had hirsutism, acne, acanthosis nigricans, and asymptomatic diabetes. Subsequent investigation revealed raised adiponectin (15.3 mg/L) and heterozygous p.Pro1205Leu mutation in the INSR gene encoding the insulin receptor. She experienced postprandial hypoglycaemia on metformin; acarbose was trialled and discontinued aged 16 years, as she became normoglycaemic. Hirsutism was treated with topical eflornithine, oral spironolactone and flutamide, and laser therapy. Unfortunately, diabetes reemerged in young adulthood with obesity. Case 2: during an emergency admission for acute abdominal pain aged 11 years, hyperglycaemia was noted which led to further investigation. An oral glucose tolerance test showed diabetes and ultrasound showed polycystic ovaries. Further investigations revealed raised adiponectin (18 mg/L) and compound heterozygous mutations in the INSR gene: p.Pro1263Ala and p.Ser748Leu (latter probable normal variant). She was treated with metformin and experienced postprandial hypoglycaemia. Symptoms of hyperandrogenism were controlled by flutamide. She maintained a healthy weight and reassessment at young adulthood showed resolution of diabetes. Type A IR may present in childhood with overlapping features of common endocrine entities such as premature adrenarche and polycystic ovarian syndrome. Patients with abnormal glucose tolerance yet normal weight merit screening with adiponectin; raised adiponectin levels prompt insulin receptor mutational analysis. Postprandial hypoglycaemia is characteristic. Management includes optimization of glycaemic control with oral hypoglycaemic agents and maintenance of healthy weight, and controlling the effects of hyperandrogenism.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  adiponectin; hyperandrogenism; hyperinsulinism; insulin receptor mutation; type A insulin resistance

Mesh:

Substances:

Year:  2017        PMID: 28093873     DOI: 10.1111/pedi.12486

Source DB:  PubMed          Journal:  Pediatr Diabetes        ISSN: 1399-543X            Impact factor:   4.866


  4 in total

1.  Clinical and Functional Characterization of Novel INSR Variants in Two Families With Severe Insulin Resistance Syndrome.

Authors:  Qiaoli Zhou; Jing Yu; Xuewen Yuan; Chunli Wang; Ziyang Zhu; Aihua Zhang; Wei Gu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-29       Impact factor: 5.555

2.  One Novel 2.43Kb Deletion and One Single Nucleotide Mutation of the INSR Gene in a Chinese Neonate with Rabson-Mendenhall Syndrome

Authors:  Xiang Chen; Huijun Wang; Bingbing Wu; Xinran Dong; Bo Liu; Hongbo Chen; Yulan Lu; Wenhao Zhou; Lin Yang
Journal:  J Clin Res Pediatr Endocrinol       Date:  2017-10-30

3.  Effects of dodder total flavone on polycystic ovary syndrome rat models induced by DHEA combined HCG.

Authors:  Mingsan Miao; Mengfan Peng; Zhengwang Zhu; Xiaoli Yan; Zhenzhen Wei; Mengyan Li
Journal:  Saudi J Biol Sci       Date:  2019-02-19       Impact factor: 4.219

4.  Type A insulin resistance syndrome misdiagnosed as polycystic ovary syndrome: a case report.

Authors:  Lu Lin; Cunren Chen; Tuanyu Fang; Daoxiong Chen; Kaining Chen; Huibiao Quan
Journal:  J Med Case Rep       Date:  2019-11-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.